跳至主要内容
临床试验/NCT01277978
NCT01277978已完成不适用

Haemodynamic Assessment at Primary Caesarean Section After Administration of Carbetocin Versus Oxytocin: a Doubleblind Randomized Trail

Medical University of Graz1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2008年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
84
试验地点
1
主要终点
Immediate hemodynamic effects of carbetocin and oxytocin

研究概览

简要总结

The purpose of this study is to evaluate the immediate effects of carbetocin and oxytocin on maternal hemodynamic parameters (heart rate and blood pressure) in a non-invasive setup (TaskeForce®-Monitor) during primary Caesarean section.

详细描述

As there is a trend toward childbearing in later life, pre-existing maternal cardiovascular problems may become more frequent during pregnancy and at delivery. In addition the increasing number of women with congenital or acquired cardiac diseases may not tolerate the induced haemodynamic changes as well as healthy patients. Therefore uterotonic drugs must be safe for the cardiovascular system.

Currently oxytocin is used as a common uterotonic agent in obstetrics. The use of this drug in uterotonic reasons can cause serious haemodynamic side effects which has been shown by several investigators.

Preliminary clinical observations of maternal heart rate and blood pressure suggest that that the use of carbetocin causes less hemodynamic changes than oxytocin.

Primary objective(s):

To evaluate the effect of carbetocin on maternal hemodynamic parameters (heart rate, blood pressure, systemic vascular resistance, cardiac output, stroke volume, heart rate variability, and blood pressure variability) in a non-invasive setup (TaskeForce®-Monitor) during primary Caesarean section.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Healthy pregnant women undergoing elective caesarean section with regional anesthesia

排除标准

  • --Women with
  • placenta praevia
  • placental abruption
  • multiple gestation
  • pregnancy related complications and disorders (i.e. preeclampsia, gestational diabetes)
  • pre-existing diseases (e.g. insulin-dependent diabetes, cardiovascular or renal diseases, thyroid disease
  • taking medication with known impact on the cardiovascular system
  • undergoing caesarean section with general anesthesia
  • secondary caesarean section

结局指标

主要结局

Immediate hemodynamic effects of carbetocin and oxytocin

时间窗: 1 day

Maternal heart rate, blood pressure, stroke volume, cardiac output, and systemic vascular resistance will be measured non-invasively. Measurements will be performed starting immediately following administration of the study medication.

次要结局

  • Adverse effects(2 day)
  • Uterotonic effect(1 day)
  • Estimation of blood loss(2 day)

研究者

发起方
Medical University of Graz
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Haemodynamic Effects of Oxytocin and Carbetocin | 临床试验